These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11995702)

  • 1. [Chronotherapy].
    Garufi C; Aschelter AM; Zappalà AR; Vanni B; Terzoli E
    Tumori; 2001; 87(6):A26-7. PubMed ID: 11995702
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronotherapy with 5-fluorouracil, oxaliplatin, and folinic acid in colorectal cancer.
    Sandor V
    Lancet; 1997 Nov; 350(9087):1325-6. PubMed ID: 9357429
    [No Abstract]   [Full Text] [Related]  

  • 3. Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Pro: The CapeOx regimen is preferred over FOLFOX.
    Chang DZ; Abbruzzese JL
    Clin Adv Hematol Oncol; 2005 May; 3(5):400-4. PubMed ID: 16167013
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumori. Chronotherapy Study Group of the European Organization for Research and Treatment of Cancer.
    Garufi C; Dogliotti L; Terzoli E; Focan C; Smaaland R; Chollet P; Perpoint B; Lévi F
    Tumori; 1999; 85(2):149-50. PubMed ID: 10363085
    [No Abstract]   [Full Text] [Related]  

  • 5. Scheduling of fluorouracil: a forget-me-not in the jungle of doublets.
    Sobrero AF
    J Clin Oncol; 2004 Jan; 22(1):4-6. PubMed ID: 14665617
    [No Abstract]   [Full Text] [Related]  

  • 6. [Future therapeutic prospectives for the treatment of advanced cancer of the colorectum: our experience with oxaliplatin combined with fluorofolates in chronoinfusions].
    Bumma C; Montrucchio G; Manzin E; Oletti MV
    Tumori; 2000; 86(3 Suppl):S26-8. PubMed ID: 10969613
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronochemotherapy].
    Dogliotti L; Garufi C; Iacobelli S
    Tumori; 2000; 86(3 Suppl):S32-6. PubMed ID: 10969615
    [No Abstract]   [Full Text] [Related]  

  • 8. Old age: biologic versus chronologic.
    Gelibter AJ; Di Segni S; Zeuli M; Milella M; Ferretti G; Nuzzo C; Cognetti F
    J Clin Oncol; 2007 Feb; 25(6):e8. PubMed ID: 17308262
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gleaning from the American Oncology Congress. A new standard in colorectal carcinoma].
    MMW Fortschr Med; 2002 Oct; 144(41):61. PubMed ID: 12474374
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxaliplatin: a welcome addition to our therapeutic armamentarium.
    Chu E
    Clin Colorectal Cancer; 2002 Aug; 2(2):72. PubMed ID: 12453318
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaco-economic comparative evaluation of combination chronotherapy vs. standard chemotherapy for colorectal cancer.
    Focan C
    Chronobiol Int; 2002 Jan; 19(1):289-97. PubMed ID: 11962682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The major response of metastatic kidney cancer to the combination of oxaliplatin, 5-fluorouracil and folinic acid (FOX-FOL)].
    Chauffert B; Bonnotte B; Chvetzoff G; Flesch M
    Presse Med; 1998 May; 27(18):859. PubMed ID: 9767871
    [No Abstract]   [Full Text] [Related]  

  • 13. Colorectal cancer: to stack or sequence therapy?
    Azvolinsky A
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25957442
    [No Abstract]   [Full Text] [Related]  

  • 14. Sequential chemotherapy for colorectal cancer.
    Seymour M
    Lancet Oncol; 2011 Oct; 12(11):987-8. PubMed ID: 21903471
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-Fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancer.
    Gholam D; Giacchetti S; Brézault-Bonnet C; Bouchahda M; Hauteville D; Adam R; Ducot B; Ghémard O; Kustlinger F; Jasmin C; Lévi F
    Oncologist; 2006; 11(10):1072-80. PubMed ID: 17110626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.
    Yao Y; Sun YJ; Zhao H; Guo YW; Lin F; Cai X; Tang XC; Tang LN; Zhang W
    Chin Med J (Engl); 2006 Nov; 119(21):1829-33. PubMed ID: 17097039
    [No Abstract]   [Full Text] [Related]  

  • 17. Stop and go: yes or no?
    Hochster HS
    J Clin Oncol; 2009 Dec; 27(34):5677-9. PubMed ID: 19786651
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequential vs combination colorectal cancer therapy sparks debate.
    Fricker J
    Br J Hosp Med (Lond); 2008 Mar; 69(3):130. PubMed ID: 18422214
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ambulatory chemotherapy schedule for metastatic colorectal cancer].
    Watine J; Soulage C
    Presse Med; 2001 Jan; 30(1):35. PubMed ID: 11210587
    [No Abstract]   [Full Text] [Related]  

  • 20. Evolution of systemic therapy for metastatic colorectal cancer.
    Geh JI; Ma YT
    Colorectal Dis; 2011 Aug; 13(8):852-4. PubMed ID: 21762349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.